SCHEMBL486233

SCHEMBL486233

Cc1cc(=O)n(-c2ccc(F)cc2)[nH]1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.69
MAPT P10636 6/20 0.69
KDM4E B2RXH2 5/20 0.69
KMT2A Q03164 5/20 0.69
GAA P10253 2/20 0.69
HTT P42858 2/20 0.69
MEN1 O00255 1/20 0.69
LMNA P02545 3/20 0.65
RECQL P46063 1/20 0.65
SMN1; SMN2 Q16637 3/20 0.63
TDP1 Q9NUW8 1/20 0.63
CTSA P10619 1/20 0.43
ALPL P05186 1/20 0.42
RAB9A P51151 2/20 0.42
NPC1 O15118 1/20 0.42
NOX4 Q9NPH5 1/20 0.42
ALKBH3 Q96Q83 1/20 0.42
ALKBH5 Q6P6C2 4/20 0.41
POLB P06746 1/20 0.41
BLM P54132 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL486125 0.85 MAPT (0.73) ALDH1A1MAPTKDM4EKMT2AGAA
SCHEMBL5203012 0.81 ALDH1A1 (0.69) ALDH1A1MAPTKDM4EKMT2AGAA
SCHEMBL8166341 0.81 ALDH1A1 (0.69) ALDH1A1MAPTKDM4EKMT2AGAA
SCHEMBL8592651 0.81 ALDH1A1 (0.69) ALDH1A1MAPTKDM4EKMT2AGAA
SCHEMBL486340 0.81 ALDH1A1 (0.69) ALDH1A1MAPTKDM4EKMT2AGAA
SCHEMBL9150171 0.81 ALDH1A1 (0.68) ALDH1A1MAPTKDM4EKMT2AGAA
SCHEMBL34121 0.81 ALDH1A1 (0.68) ALDH1A1MAPTKDM4EKMT2AGAA
SCHEMBL5425653 0.81 ALDH1A1 (0.68) ALDH1A1MAPTKDM4EKMT2AGAA
SCHEMBL4338380 0.81 MAPT (0.63) ALDH1A1MAPTKDM4EKMT2AGAA
SCHEMBL23907023 0.79 MAPT (0.65) ALDH1A1MAPTKDM4EKMT2AGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107674028-A A kind of synthetic method of pyrazoline ketone compounds 天津瑞岭化工有限公司 2018-02-09 CN disclosed
CN-107652237-A A kind of synthetic method of pyrazolone and its derivative 天津瑞岭化工有限公司 2018-02-02 CN disclosed
US-8957102-B2 Heterocyclic compound as protein kinase inhibitor NEOPHARM CO., LTD. (KR) 2015-02-17 US disclosed
US-8957102-B2 Heterocyclic compound as protein kinase inhibitor NEOPHARM CO., LTD. (KR) 2015-02-17 US disclosed
EP-2145884-B1 INDOLEDIONE DERIVATIVE MSD KK (JP) 2014-08-06 EP disclosed
US-20120289509-A1 HETEROCYCLIC COMPOUND AS PROTEIN KINASE INHIBITOR NEOPHARM CO., LTD. (KR) 2012-11-15 US disclosed
US-20120289509-A1 HETEROCYCLIC COMPOUND AS PROTEIN KINASE INHIBITOR NEOPHARM CO., LTD. (KR) 2012-11-15 US disclosed
US-8106086-B2 Indoledione derivative MSD K.K. (JP) 2012-01-31 US disclosed
US-20110183983-A1 HETEROCYCLIC COMPOUND AS PROTEIN KINASE INHIBITOR NEOPHARM CO., LTD. (KR) 2011-07-28 US disclosed
US-20110183983-A1 HETEROCYCLIC COMPOUND AS PROTEIN KINASE INHIBITOR NEOPHARM CO., LTD. (KR) 2011-07-28 US disclosed
EP-2145884-A1 INDOLEDIONE DERIVATIVE BANYU PHARMACEUTICAL CO., LTD. (JP) 2010-01-20 EP disclosed
EP-1334998-B1 METAL COMPLEX TYPE SQUARYLIUM COMPOUNDS AND OPTICAL RECORDING MEDIA MADE BY USING THE SAME KYOWA HAKKO CHEMICAL CO LTD (JP) 2006-08-02 EP disclosed
US-6670387-B1 Thrombocytopenia; hydroxy-1-azo-naphthalene derivatives; 3-hydroxy-4-((2-hydroxy-1-naphthalenyl)azo-)-1-naphthalenesul fonic acid; promoters of thrombopoiesis and megakaryocytopoi esis; enhancing platelet production; agonizing TPO receptor SMITHKLINE BEECHAM CORPORATION 2003-12-30 US disclosed
US-6660867-B2 Squarylium compounds having spectroscopic properties, light resistance, solubility and thermal decomposition properties suitable for a recording material for DVD-R, and optical recording media using the same KYOWA HAKKO KOGYO CO., LTD. (JP) 2003-12-09 US disclosed
US-20030187272-A1 Metal complex type squarylium compounds and optical recording media made by using the same KYOWA HAKKO CHEMICAL CO., LTD. (FORMERLY KYOWA YUKA CO., LTD.) (JP) 2003-10-02 US disclosed
EP-1334998-A1 METAL COMPLEX TYPE SQUARYLIUM COMPOUNDS AND OPTICAL RECORDING MEDIA MADE BY USING THE SAME KYOWA HAKKO KOGYO CO., LTD. (JP) 2003-08-13 EP disclosed
EP-1156804-A4 THROMBOPOIETIN MIMETICS SMITHKLINE BEECHAM CORP (US) 2002-08-07 EP disclosed
EP-1156804-A1 THROMBOPOIETIN MIMETICS SMITHKLINE BEECHAM CORPORATION (US) 2001-11-28 EP disclosed
WO-2000035446-A1 THROMBOPOIETIN MIMETICS SMITHKLINE BEECHAM CORPORATION (US) 2000-06-22 WO disclosed
US-4169091-A Symmetrical and asymmetrical disazo compounds containing a bis-(nitro-aryloxy)alkane middle component HOECHST AKTIENGESELLSCHAFT (DE) 1979-09-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110183983-A1 HETEROCYCLIC COMPOUND AS PROTEIN KINASE INHIBITOR MET, HGFAC, DMPK ALDH1A1 3427/4885MAPT 3424/4885KDM4E 1560/4885
US-20030187272-A1 Metal complex type squarylium compounds and optical recording media made by using the same DCLK2, DCLK3, DCLK1 ALDH1A1 2113/4885MAPT 3668/4885KDM4E 1359/4885
US-20120289509-A1 HETEROCYCLIC COMPOUND AS PROTEIN KINASE INHIBITOR MET, HGFAC, DMPK ALDH1A1 3427/4885MAPT 3424/4885KDM4E 1560/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.